Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Taro Tamaki
NK-104, a Newly Developed HMG-CoA Reductase Inhibitor, Suppresses Neointimal Thickening by Inhibiting Smooth Muscle Cell Growth and Fibronectin Production in Balloon-Injured Rabbit Carotid Artery.
The Japanese Journal of Pharmacology
Related publications
Effects of an HMG-CoA Reductase Inhibitor on Cytokine Production by Human Monocytes/Macrophages.
Journal of Nippon Medical School
Mechanism of HMG-CoA Reductase Inhibitor-Induced Contractile Dysfunction in Rat Cultured Skeletal Muscle
Biophysical Journal
Biophysics
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (3). Foeto-Placental Transfer and Mammary Excretion After Oral Administration in Rats.
Drug Metabolism and Pharmacokinetics
Potential Role of HMG CoA Reductase Inhibitor on Oxidative Stress Induced by Advanced Glycation Endproducts in Vascular Smooth Muscle Cells of Diabetic Vasculopathy
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Local Delivery of Heparin Inhibits Neointimal Hyperplasia in Injured Rabbit Artery.
Japanese Heart Journal
Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Antimetastatic and Antitumorigenic Effects in Endometrial Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase Signaling
PLoS ONE
Multidisciplinary
Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL From Oxidative Modification in Hypercholesterolemic Rabbits.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
